Search research articles
Contact Us
Filters
Showing results (381-390 of 713) with videos related to
Page
of 72
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
August 12, 2011
The clinical significance of achieving different levels of cytogenetic response in patients with chronic phase chronic myeloid leukemia after failure to front-line therapy: is complete cytogenetic response the only desirable endpoint?
Jorge Cortes, Alfonso Quintas-Cardama, Elias Jabbour, et al.
Leukemia Research
|
April 28, 2004
C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome
Anne S Tsao, Hagop Kantarjian, Deborah Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis
Alfonso Quintás-Cardama, Hagop M Kantarjian, Taghi Manshouri, et al.
Cancer
|
June 19, 2009
Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial
Nitin Jain, James M Reuben, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 24, 2013
Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome
Hady Ghanem, A Megan Cornelison, Guillermo Garcia-Manero, et al.
Blood
|
November 2, 2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies
Jorge Cortes, Maher Albitar, Deborah Thomas, et al.
Therapeutic Advances in Hematology
|
April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure
Hady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
Hematology Reports
|
February 25, 2025
The Role of Ferritin and Folate in Determining Stem Cell Collection for Autologous Stem Cell Transplant in Multiple Myeloma
Charles J Weeks, Mohammad Mian, Michael Stokes, et al.
Blood
|
July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
Koichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
Haematologica
|
October 15, 2020
The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis
Mahran Shoukier, Gautam Borthakur, Elias Jabbour, et al.
Page
of 72
Search research articles
Search
Showing results (381-390 of 713) with videos related to
Sort By:
Page
of 72
Clinical Lymphoma, Myeloma & Leukemia
|
August 12, 2011
The clinical significance of achieving different levels of cytogenetic response in patients with chronic phase chronic myeloid leukemia after failure to front-line therapy: is complete cytogenetic response the only desirable endpoint?
Jorge Cortes, Alfonso Quintas-Cardama, Elias Jabbour, et al.
Leukemia Research
|
April 28, 2004
C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome
Anne S Tsao, Hagop Kantarjian, Deborah Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis
Alfonso Quintás-Cardama, Hagop M Kantarjian, Taghi Manshouri, et al.
Cancer
|
June 19, 2009
Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial
Nitin Jain, James M Reuben, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 24, 2013
Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome
Hady Ghanem, A Megan Cornelison, Guillermo Garcia-Manero, et al.
Blood
|
November 2, 2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies
Jorge Cortes, Maher Albitar, Deborah Thomas, et al.
Therapeutic Advances in Hematology
|
April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failure
Hady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
Hematology Reports
|
February 25, 2025
The Role of Ferritin and Folate in Determining Stem Cell Collection for Autologous Stem Cell Transplant in Multiple Myeloma
Charles J Weeks, Mohammad Mian, Michael Stokes, et al.
Blood
|
July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
Koichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
Haematologica
|
October 15, 2020
The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis
Mahran Shoukier, Gautam Borthakur, Elias Jabbour, et al.
Page
of 72